Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: A pilot prospective case-control study

Flavio Gaspari, Paolo Cravedi, Mario Mandalà, Norberto Perico, Felipe Rodríguez De Leon, Nadia Stucchi, Silvia Ferrari, Roberto Labianca, Giuseppe Remuzzi, Piero Ruggenenti

Research output: Contribution to journalArticlepeer-review

Abstract

Background/Aims: Nephrotoxicity is the major limitation to cisplatin therapy for solid tumors. We aimed at evaluating whether early increases in serum/urine levels of neutrophil gelatinase-associated lipocalin (NGAL), a biomarker of tubular damage and regeneration, predict cisplatin-induced acute kidney injury (AKI). Methods: We compared changes in serum creatinine and serum/urine NGAL levels (ELISA assay) at 1 and 4 h and 1, 2, 3, 7 and 15 days after cisplatin infusion (70-80 mg/m2) versus baseline in 12 consecutive cancer patients (cases) with AKI (>25% serum creatinine increase vs. baseline) and 12 consecutive controls without AKI. Results: Baseline characteristics and posttreatment serum NGAL levels were similar in both groups. Urinary NGAL levels increased significantly more in cases than in controls at 1, 2, 3 and 15 days after cisplatin. The NGAL increase preceded AKI by 4.5 days and the NGAL increase at day 2 after cisplatin independently predicted AKI (p <0.05). Six cases with residual kidney dysfunction at 15 days showed a trend to earlier and higher increase in urinary NGAL levels compared to cases with renal function recovery. Conclusion: An early increase in urinary NGAL excretion may help in identifying patients at risk of cisplatin-induced AKI who might benefit from innovative treatments to prevent cisplatin nephrotoxicity.

Original languageEnglish
JournalNephron - Clinical Practice
Volume115
Issue number2
DOIs
Publication statusPublished - Jun 2010

Keywords

  • Acute kidney injury
  • Cancer
  • Cisplatin
  • Neutrophil gelatinase-associated lipocalin

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: A pilot prospective case-control study'. Together they form a unique fingerprint.

Cite this